Literature DB >> 21296684

Toward specific cardiac I(K1) modulators for in vivo application: old drugs point the way.

Marcel A G van der Heyden1, José A Sánchez-Chapula.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21296684     DOI： 10.1016/j.hrthm.2011.01.038

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN： 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  7 in total

1.  Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP2 interference.

Authors:  Daniel Scherer; Benedikt Schworm; Claudia Seyler; Panagiotis Xynogalos; Eberhard P Scholz; Dierk Thomas; Hugo A Katus; Edgar Zitron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-04-02       Impact factor: 3.000

Review 2.  Novel molecular targets for atrial fibrillation therapy.

Authors:  Dobromir Dobrev; Leif Carlsson; Stanley Nattel
Journal:  Nat Rev Drug Discov       Date:  2012-03-30       Impact factor: 84.694

3.  Mechanisms for Kir channel inhibition by quinacrine: acute pore block of Kir2.x channels and interference in PIP2 interaction with Kir2.x and Kir6.2 channels.

Authors:  Angélica López-Izquierdo; Iván A Aréchiga-Figueroa; Eloy G Moreno-Galindo; Daniela Ponce-Balbuena; Martín Rodríguez-Martínez; Tania Ferrer-Villada; Aldo A Rodríguez-Menchaca; Marcel A G van der Heyden; José A Sánchez-Chapula
Journal:  Pflugers Arch       Date:  2011-07-22       Impact factor: 3.657

4.  Inhibiting the clathrin-mediated endocytosis pathway rescues K(IR)2.1 downregulation by pentamidine.

Authors:  Rosanne Varkevisser; Marien J C Houtman; Maaike Waasdorp; Joyce C K Man; Raimond Heukers; Hiroki Takanari; Ralph G Tieland; Paul M P van Bergen En Henegouwen; Marc A Vos; Marcel A G van der Heyden
Journal:  Pflugers Arch       Date:  2012-11-29       Impact factor: 3.657

5.  Finding inward rectifier channel inhibitors: why and how?

Authors:  Marcel A G van der Heyden
Journal:  Front Pharmacol       Date:  2012-01-09       Impact factor: 5.810

6.  Efficacy of pentamidine analogue 6 in dogs with chronic atrial fibrillation.

Authors:  Viktor Szatmári; Yuan Ji; Bianca van Herwijnen; Mei Feng; Michael Zhou Wang; Alexandre Bossu; Marcel A G van der Heyden
Journal:  J Vet Intern Med       Date:  2018-08-05       Impact factor: 3.333

Review 7.  Towards the Development of AgoKirs: New Pharmacological Activators to Study Kir2.x Channel and Target Cardiac Disease.

Authors:  Laura van der Schoor; Emma J van Hattum; Sophie M de Wilde; Netanja I Harlianto; Aart-Jan van Weert; Meye Bloothooft; Marcel A G van der Heyden
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.